Latest News for: keros

Edit

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda (Form 8-K) (Keros Therapeutics Inc)

Public Technologies 29 Sep 2026
) Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda. LEXINGTON, Mass., September 29, 2026, (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (Nasdaq ... About Keros Therapeutics, Inc.
Edit

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

Nasdaq Globe Newswire 29 Sep 2026
LEXINGTON, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq ... .
Edit

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept ...

Nasdaq Globe Newswire 28 Sep 2026
Initial data expected in the first half of 2027. Initial data expected in the first half of 2027 ... .
Edit

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD (Form 8-K) (Keros Therapeutics Inc)

Public Technologies 28 Sep 2026
) Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD ... LEXINGTON, Mass., September 28, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (Nasdaq.
Edit

Notice of Effectiveness (Form EFFECT) (Keros Therapeutics Inc)

Public Technologies 17 Sep 2026
Keros Therapeutics, Inc ... Keros Therapeutics Inc published this content on September 16, 2026, and is solely ...
Edit

Delaying Amendment to Registration Statement (Form DEL AM) (Keros Therapeutics Inc)

Public Technologies 11 Sep 2026
Keros Therapeutics, Inc ... Delaying Amendment for Keros Therapeutics, Inc ... 333-298854) filed with the Securities and Exchange Commission (the "Commission") by Keros Therapeutics, Inc ... KEROS THERAPEUTICS, INC.
Edit

Registration Statement - Specified Transactions (Form S-3) (Keros Therapeutics Inc)

Public Technologies 10 Sep 2026
Keros Therapeutics, Inc ... Keros Therapeutics, Inc ... Keros Therapeutics, Inc ... Keros Therapeutics, Inc. was originally incorporated under the laws of the State of Delaware under the name Keros Therapeutics, Inc ... Keros Therapeutics, Inc.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Keros Therapeutics Inc)

Public Technologies 06 Jul 2026
0.5 ... 2 ... Keros Therapeutics, Inc ... C/O KEROS THERAPEUTICS, INC., 1050 WALTHAM STREET, SUITE 302 4 ... 5 ... C/O KEROS THERAPEUTICS, INC ... Keros Therapeutics Inc published this content on July 06, 2026, and is solely responsible for the information contained herein.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Keros Therapeutics Inc)

Public Technologies 06 Jul 2026
0.5 ... 2 ... Keros Therapeutics, Inc ... C/O KEROS THERAPEUTICS, INC., 1050 WALTHAM STREET, SUITE 302 3 ... 6 ... C/O KEROS THERAPEUTICS, INC ... Keros Therapeutics Inc published this content on July 06, 2026, and is solely responsible for the information contained herein.
  • 1

Article Search

tools
×
×
×
×